Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity |
| |
Authors: | Sheng Matilda H-C Wergedal Jon E Mohan Subburaman Lau K-H William |
| |
Affiliation: | Musculoskeletal Disease Center (151), Jerry L. Pettis Memorial VA Medical Center, Loma Linda, CA 92357, USA. Matilda.Sheng@va.gov |
| |
Abstract: | This study presents gene expression, protein expression, and in situ immunohistochemical evidence that osteoclasts express high levels of osteoactivin (OA), which had previously been reported to be an osteoblast-specific protein in bone. OA expression in osteoclasts was up-regulated upon receptor activator of NFkappaB ligand-induced differentiation. Suppression of functional activity of OA with neutralizing antibody reduced cell size, number of nuclei, fusion, and bone resorption activity of osteoclasts. OA was co-immunoprecipitated with integrin beta3 and beta1, indicating that OA co-localizes with integrin beta3 and/or beta1 in a hetero-polymeric complex in osteoclasts. These findings indicate that OA is a novel osteoclastic protein and plays a role in osteoclast differentiation and/or activity. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|